<?xml version="1.0" encoding="UTF-8"?>
<p>Various research groups have reported the hepatoprotective potential of naringenin [
 <xref rid="B11-plants-09-01784" ref-type="bibr">11</xref>,
 <xref rid="B96-plants-09-01784" ref-type="bibr">96</xref>,
 <xref rid="B97-plants-09-01784" ref-type="bibr">97</xref>,
 <xref rid="B98-plants-09-01784" ref-type="bibr">98</xref>,
 <xref rid="B99-plants-09-01784" ref-type="bibr">99</xref>,
 <xref rid="B100-plants-09-01784" ref-type="bibr">100</xref>,
 <xref rid="B101-plants-09-01784" ref-type="bibr">101</xref>], which is attributed to its potential in neutralizing the ROS via increased expression and activation of antioxidant enzymes [
 <xref rid="B102-plants-09-01784" ref-type="bibr">102</xref>,
 <xref rid="B103-plants-09-01784" ref-type="bibr">103</xref>] and the ability to amend gamma-glutamylcysteine synthetase (GGT) enzyme activity, which is involved in the GSH synthesis pathway [
 <xref rid="B104-plants-09-01784" ref-type="bibr">104</xref>,
 <xref rid="B105-plants-09-01784" ref-type="bibr">105</xref>,
 <xref rid="B106-plants-09-01784" ref-type="bibr">106</xref>]. Reportedly, pre-treatment with naringenin causes a decline in levels of AST and ALT, while antioxidant parameters, viz GPx, SOD, CAT, and GSH, have shown a significant increase [
 <xref rid="B101-plants-09-01784" ref-type="bibr">101</xref>,
 <xref rid="B107-plants-09-01784" ref-type="bibr">107</xref>]. The groups of rats intoxicated with CCl4 have shown repression of caspase-3 and -9 levels [
 <xref rid="B108-plants-09-01784" ref-type="bibr">108</xref>]. In a recently published article by Wu et al., the hepatoprotective action of naringenin has been attributed to its potential in inhibiting hepatic oxidative stress and inflammation [
 <xref rid="B109-plants-09-01784" ref-type="bibr">109</xref>].
</p>
